Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Edrophonium chloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for edrophonium chloride and what is the scope of edrophonium chloride freedom to operate?

Edrophonium chloride
is the generic ingredient in six branded drugs marketed by Organon Usa Inc, Hospira, Watson Labs, Teligent, and Mylan Institutional, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for edrophonium chloride. One supplier is listed for this compound.

Summary for Generic Name: edrophonium chloride

Tradenames:6
Patents:1
Applicants:5
NDAs:6
Drug Master File Entries: see list3
Suppliers / Packagers: see list1
Bulk Api Vendors: see list49
Clinical Trials: see list195
Patent Applications: see list2,696
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:edrophonium chloride at DailyMed

Pharmacology for Ingredient: edrophonium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
EDROPHONIUM CHLORIDE PRESERVATIVE FREE
edrophonium chloride
INJECTABLE;INJECTION040043-001Mar 20, 1996DISCNNoNo► Subscribe► Subscribe
Mylan Institutional
ENLON
edrophonium chloride
INJECTABLE;INJECTION088873-001Aug 6, 1985RXNoYes► Subscribe► Subscribe
Hospira
EDROPHONIUM CHLORIDE
edrophonium chloride
INJECTABLE;INJECTION040131-001Feb 24, 1998DISCNNoNo► Subscribe► Subscribe
Teligent
TENSILON
edrophonium chloride
INJECTABLE;INJECTION007959-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Organon Usa Inc
REVERSOL
edrophonium chloride
INJECTABLE;INJECTION089624-001May 13, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot